Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 7,213 |
|
|||||
| News | - | ||||||
| Day High | 39.645 | Low High |
|||||
| Day Low | 39.06 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| SPDR S&P Pharmaceuticals | XPH | AMEX | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.555 | 1.42% | 39.645 | 15:16:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.06 | 39.06 | 39.645 | 39.09 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 156 | 7,213 | 39.26 | 283,162 | - | 34.6704 - 45.62 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 15:16:07 | 50 | 39.622 | USD |
SPDR S&P Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 214.06M | 5.40M | - | 3.54M | -5.01M | -0.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News SPDR S&P Pharmaceuticals
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XPH Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.04 | 40.00 | 38.88 | 39.31 | 30,430 | 0.605 | 1.55% |
| 1 Month | 43.41 | 43.41 | 38.88 | 40.60 | 35,590 | -3.76 | -8.67% |
| 3 Months | 42.46 | 45.62 | 38.88 | 42.63 | 36,351 | -2.82 | -6.63% |
| 6 Months | 36.22 | 45.62 | 34.6704 | 40.63 | 48,583 | 3.43 | 9.46% |
| 1 Year | 41.54 | 45.62 | 34.6704 | 40.88 | 42,748 | -1.90 | -4.56% |
| 3 Years | 49.60 | 53.82 | 34.6704 | 43.97 | 57,565 | -9.96 | -20.07% |
| 5 Years | 39.84 | 56.32 | 30.30 | 43.19 | 66,877 | -0.195 | -0.49% |
| The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). |
